Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Effectiveness of Short-course AmBisome in the Treatment of Post-Kala-azar Dermal Leishmaniasis (PKDL): a Prospective Cohort Study in Bangladesh

NCT03311607 is registered in ClinicalTrials.gov with Medecins Sans Frontieres, Netherlands as lead sponsor.

NCT NCT03311607
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03311607 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Effectiveness of Short-course AmBisome in the Treatment of Post-Kala-azar Dermal Leishmaniasis (PKDL): a Prospective Cohort Study in Bangladesh
Lead sponsor
Medecins Sans Frontieres, Netherlands
Phase
Phase 4
Overall status
Completed
Start date
April 8, 2014
Completion date
October 14, 2015
Enrollment
280 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

post-kala-azar dermal leishmaniasis